Skip to content

Meet the Team

TEMIT is managed by an experienced investment team comprising of the following members:

Chetan Sehgal, CFA

Senior Managing Director, Director of Portfolio Management

Andrew Ness

Portfolio Manager, Franklin Templeton Emerging Markets Equity

Overview

Emerging Market (EM) stocks rose in August 2026. Memory stocks regained their footing and recovered from July’s technology sell-off. However, sentiment was periodically challenged by elevated US treasury yields, renewed tensions within the Middle East and continued debate over the sustainability of artificial intelligence (AI)-related investments. For the month, the MSCI Emerging Markets Index returned 2.60%. The MSCI World Index delivered 1.82%, both in net UK-sterling terms.1

The emerging Asia region recovered and gained. However, performance was uneven. Technology stocks in both South Korea and Taiwan recovered following last month’s sharp correction. Chinese equities pulled back, with large-capitalisation internet platforms pressured by concerns over the scale and returns of AI investments. Indian equities fell as well, weighed in part by higher crude oil prices. Leadership and governance uncertainty at a major Indian conglomerate also weighed on several group companies.

Equities in the emerging Europe, Middle East and Africa region rose, despite continued geopolitical uncertainty and volatility in energy prices. South African equities lifted regional returns, helped by gains in gold and platinum miners as prices of precious metals strengthened.

Equities in the emerging Latin America (LatAm) region fell. The weakness was partially driven by Brazilian equities. A leading Brazilian retailer filed for bankruptcy protection, adding to concerns around banking-sector credit quality given exposures among several lenders. The month also saw foreign outflows in Brazil following a period of early-year gains and pre-election jitters. In Mexico, rising global metal prices supported the share prices of major mining companies.

Portfolio Changes & Positioning

During the period, we increased our position in Dr Reddy’s Laboratories, an India-based pharmaceutical company that manufactures and markets a wide range of products in India and abroad. Following a share price correction in July, we find the risk-reward ratio attractive at current valuations. At the company level, Dr Reddy’s is increasing its focus on higher-value areas, including complex generics and biosimilars. Its strong balance sheet and net cash position also provide financial flexibility.

Overall, we increased investments in the financials and communication services sectors. In terms of countries, we undertook purchases in China/Hong Kong and Brazil.

We trimmed our position in MediaTek, a Taiwan-based semiconductor company evolving into a more diversified compute-chip provider. Following strong year-to-date share-price performance, we reduced our exposure slightly to manage its active weight in the portfolio.

By sector, we reduced our exposure to information technology, utilities and industrials. Geographically, we made the biggest sales in South Korea, Taiwan and Hungary.

Positive Contributors

TEMIT’s net asset value returned 2.87% over the month, compared to the MSCI EM Index-NR’s result of 2.60%, both in UK-sterling terms.

Lite-On Tech is a provider of optoelectronic semiconductor components and power management modules. The company released its second-quarter results in late July, which were quite strong. Wuxi Biologics is a Chinese contract development and manufacturing organisation. Its share price rose due to a results beat for the first half of 2026. South Korean holding company LG Corp rounded out the top three relative contributors. LG Corp owns stakes in several companies across various industries such as electronics, chemicals, EV (electric vehicle) batteries and household products.

Detractors

The largest detractor was BYD, a leading electric vehicle (EV) and battery manufacturer in China. Its share price traded downwards after rising in the previous month of July. Concerns on the European Union’s plug-in hybrid EV tariff risk weighed on the share price. BYD also released its second-quarter results, which were in-line with expectations and signalled that earnings might have reached a trough. We remain positive on the company’s growing international presence and product innovation, including its newly launched flash-charging technology. These factors, together with a potential stabilisation in domestic demand, could support its longer-term financial performance.

Additionally, the share prices of Itau Unibanco (a Brazilian bank providing a broad range of services such as cards, loans and insurance) and Prosus (a leading global investment company) fell and pressured the portfolio.

Newsletter Subscription

Subscribe to receive emails containing portfolio manager commentary, factsheets, market insights and other relevant information straight to your inbox.

Sign up to receive emails

Outlook

Looking ahead, we expect returns to remain differentiated across sectors. We continue to see opportunities in information technology, supported by investment in AI infrastructure. EM companies, particularly in Asia, play an important role in the global semiconductor and AI supply chain, and have benefited from this investment cycle. We continue to monitor the pace of AI spending and the sustainability of earnings growth across AI-related companies. Leading memory players also announced new improved shareholder return policies during the month.  

Beyond AI, we continue to see opportunities across other structural themes, including industrial upgrading, electrification and financial deepening. These include companies benefiting from investment in power and infrastructure, as well as well-capitalised banks operating in under-penetrated financial systems. 

Overall, EMs offer a range of opportunities. Investors can gain exposure to long-term growth trends, reasonable valuations and earnings potential. 

The information provided is not a recommendation to purchase, sell, or hold any particular security and is not to be taken as advice. It should not be assumed that any securities transactions were or will be profitable.

  1. Source: MSCI. The MSCI World Index captures large- and mid-capitalisation representation across 23 developed market countries. The MSCI Emerging Markets Index captures large- and mid-cap representation across 24 emerging market (EM) countries. Indexes are unmanaged and one cannot directly invest in them. They do not include fees, expenses or sales charges. Past performance is not an indicator or guarantee of future results. MSCI makes no warranties and shall have no liability with respect to any MSCI data reproduced herein. No further redistribution or use is permitted. This report is not prepared or endorsed by MSCI. Important data provider notices and terms available at www.franklintempletondatasources.com

WHAT ARE THE KEY RISKS?

The value of shares in the Templeton Emerging Markets Investment Trust PLC (TEMIT) and any income received from it can go down as well as up and investors may not get back the full amount invested. There is no guarantee that TEMIT will meet its objective. TEMIT invests in the equity securities of emerging markets companies. Emerging markets have historically been subject to significant price movements, often to a greater extent than more established equity markets. As a result, the share price and net asset value of TEMIT can fluctuate over time. Performance may also be affected by currency fluctuations. TEMIT can borrow to purchase assets for the company; this will magnify any gains or losses made by the company. Shares of TEMIT are bought and sold on stock exchanges, typically, at any given time on any given day, the price you pay for a share will be higher than the price at which you could sell it. In addition, investors should be aware that TEMIT may trade at a discount to its Net Asset Value (NAV) per Share, and such discount may become larger in the future. TEMIT may take charges from the Company’s capital account. While this might allow a larger dividend to be distributed, it may also have the effect of reducing capital. For more details of all the risks applicable to TEMIT, please refer to the Key Information Document, Investor Disclosure Document and the risk section in TEMIT’s Annual Report, which can be downloaded from our website – www.temit.co.uk.
 

IMPORTANT INFORMATION

This material is intended to be of general interest only and should not be construed as investment advice. It does not constitute legal or tax advice nor is it an offer for shares or invitation to apply for shares of Templeton Emerging Markets Investment Trust PLC (“TEMIT”). TEMIT is an alternative investment fund (“AIF”) for the purposes of the UK AIFM Directive and is incorporated as a public limited Company in Scotland.

Opinions expressed are the author’s at publication date and they are subject to change without prior notice. Investments in shares in TEMIT should only be made on the basis of the Investor Disclosure and Key Information Documents, accompanied by the latest available audited annual report and the latest semi-annual report if published thereafter.

Shares in investment trusts are traded on a stockmarket. The share price of investment trusts fluctuate in accordance with supply and demand and may not reflect the value of underlying net asset value of the shares.

TEMIT shall not be liable to any user of this material or to any other person or entity for the inaccuracy of information or any errors or omissions in its contents, regardless of the cause of such inaccuracy, error or omission. Any opinions expressed are the author's at publication date and they are subject to change without prior notice. Any research and analysis contained in this material has been procured by TEMIT for its own purposes and is provided to you only incidentally. Data from third party sources may have been used in the preparation of this material and TEMIT has not independently verified, validated or audited such data.

There is no guarantee TEMIT will meet its objective. The value of shares in TEMIT and income received from it can go down as well as up, and investors may not get back the full amount invested. Past performance is not an indicator or a guarantee of future performance. An investment in TEMIT entails risks. In emerging markets, the risks can be greater than in developed markets.

Investment trusts may borrow money in order to make further investments. This is known as 'gearing' and can enhance shareholder returns in rising markets but, conversely, can reduce them in falling markets. The majority of charges will be deducted from the capital of the company. This will constrain capital growth of the company in order to maintain the income streams. TEMIT may use financial derivatives or other instruments which entail specific risks more fully described in the company's documents.

TEMIT invests in the equity securities of emerging markets companies. Emerging markets have historically been subject to significant price movements, often to a greater extent than more established equity markets. As a result, the share price and net asset value of TEMIT can fluctuate over time. Performance may also be affected by currency f luctuations. For details of all the risks applicable to TEMIT, please refer to the Key Information Document, Investor Disclosure Document and the Principal and Emerging risks sections in the Annual Report. These documents can be found on our website: https://www.temit.co.uk/resources/literature or can be obtained, free of charge from the address below. TEMIT shares are not registered, marketed or promoted to US Persons. Shares of TEMIT are available for sale on the London and New Zealand stock exchanges.

References to indices are made for comparative purposes only and are provided to represent the investment environment existing during the time periods shown. Indices are unmanaged, and one cannot invest directly in an index. They do not reflect any fees, expenses or sales charges. lAll index data is provided “as is.”

The portfolio described herein is not sponsored or endorsed by MSCI. In no event shall MSCI, its affiliates or any MSCI data provider have any liability of any kind in connection with the MSCI data or the portfolio described herein. Copying or redistributing the MSCI data is strictly prohibited. © 2026 Morningstar, Inc. All rights reserved. You will find more information at www.morningstar.com

Franklin Templeton Investment Trust Management Ltd (registered in Scotland SC460631) is the Alternative Investment Fund Manager to Alternative Investment Funds.

Issued by Franklin Templeton Investment Management Limited (FTIML), Cannon Place, 78 Cannon Street, London EC4N 6HL. FTIML is authorised and regulated by the Financial Conduct Authority. Information about TEMIT can be found on the TEMIT website https://www.temit.co.uk

Important data provider www.franklintempletondatasources.com.

CFA® and Chartered Financial Analyst® are trademarks owned by CFA Institute.